you are right message2ben
the contradictions keep mounting
- waiting for understanding of true asset value at the same time saying there are no longer large upfornt payements possible
- believe we have the potnetial of humira, but we have to start with highest label price as very hard to raise prices after they are set - humira consistantly raised prices for years and years. they paid consultants for these gems of information
- massive interest from big pharma (32 signed nda/s for data room), yet zero term-sheets or offers of interest
research reports and media, page-3889
-
- There are more pages in this discussion • 422 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.5¢ |
Change
-0.010(3.77%) |
Mkt cap ! $89.19M | |||
| Open | High | Low | Value | Volume |
| 27.0¢ | 27.0¢ | 25.5¢ | $162.7K | 620.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 25008 | 25.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.0¢ | 34768 | 1 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| PAR (ASX) Chart |